Earnings call transcript: Check Point Q3 2026 shares fall on cautious outlook

Check Point reported Q3 revenue of $669.8 million, down 1% year over year and about $2.3 million below estimates; non-GAAP EPS of $2.49 matched forecasts. Subscription revenue rose 11% to $339 million, while adjusted free cash flow was $258 million, but management described the recovery as gradual and guided for flat year-over-year revenue growth at the Q4 midpoint of $745 million. Shares fell 4.67% to $145 in premarket trading. The company repurchased 2.5 million shares for $325 million during the quarter.

Analysis

CHKP’s risk is less the small revenue miss than the quality and timing of the recovery: postponed appliance refreshes also weaken maintenance and services, so product stabilization alone may not quickly restore the broader revenue engine. Management attributes delays mainly to execution and customer timing; if refresh cycles are lengthening or workloads are shifting to service models, the “trough” could prove temporary rather than a clean inflection.

The growth counterweight is real but needs scale verification. Emerging-product ARR and billing growth can coexist with only 11% subscription revenue growth, while lower appliance refreshes also reduce attached subscriptions. The announced firewall price increase is not equivalent to durable demand: management says full capture could add up to three points of revenue growth, but historical realization was less than half of the increase. Separately, roughly $50 million of potential incremental 2027 FX expense and sales-force investment make operating leverage vulnerable even if revenue improves. Buybacks support per-share results, but do not resolve execution risk.

Near term, the premarket decline looks like repricing of a gradual, not rapid, recovery; avoid assuming the selloff is an automatic entry. Over 1–3 months, Q4 delivery against the $745 million revenue midpoint and evidence on product bookings, renewals, and subscription growth matter more than pipeline commentary. Over 6–18 months, AI/data-center security and sovereign deployments are options, not yet demonstrated offsets. The contrarian upside is that delayed refreshes may be deferred rather than lost and newer products could open new buyers; the downside is that sales-force expansion and portfolio repositioning take longer to convert. February strategy targets and subsequent 2027 margin guidance are key tests.

Key Decisions for Investors

• Keep CHKP underweight / do not buy the post-earnings dip yet. Reassess after Q4 results: revenue at or above the $745 million midpoint, improving product bookings, and subscription growth holding near double digits would weaken the cautious thesis; a miss or renewed subscription deceleration would reinforce it.
• Do not underwrite the price increase as a full growth catalyst. Track realized renewal uplift and customer retention; weaker renewal rates or evidence that discounting offsets list-price changes would falsify the expected benefit.
• Treat 2027 AI-security and sovereign-data-center opportunities as a watch item, not a forecast: seek disclosed recurring revenue, customer conversions, or material bookings before paying for that optionality.
• Monitor operating leverage alongside growth. The thesis improves if revenue acceleration absorbs sales investment and FX expense without material margin erosion; weaker margins despite improving sales would signal that the recovery is not translating into earnings.